SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

CTech’s Book Review: What strategy really is and why so many organizations get it wrong

British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”

The end-of-year tech layoffs are not a crisis - they mark a paradigm shift

MSC denies interest in acquiring ZIM

Buzz

Most popular

Daily

Weekly

1

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

2

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

3

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

4

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

5

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

Richard Francis

3 stories about Richard Francis

מטה טבע כפר סבא

Teva surpasses expectations in Q4 but sets cautious outlook for 2025

29.01.25|Sophie Shulman

Despite a strong finish to the year, Teva forecasts lower-than-expected earnings and revenue growth for 2025.

ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva soars with double-digit growth in Q3, raises annual forecast

06.11.24|Sophie Shulman

Strong sales of Austedo and Ajovy push Teva’s revenues above expectations, with the company forecasting up to $16.5 billion in 2024.

מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva CEO: "The company played not to lose, now we’ll play to win"

21.02.24|Sophie Shulman

Richard Francis' decision to focus on innovative drugs has boosted the stock by 40% since he took office. However, the high debt is still burdensome and the realization of the potential depends on the success of developments that are still in the laboratory